Skip to content

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

  • Home
  • Infectious Disease
  • Metabolic
  • Neurological
  • Nutrition
  • Public Health

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

  • Home
  • Infectious Disease
  • Metabolic
  • Neurological
  • Nutrition
  • Public Health
Global Drug-Resistant Tuberculosis Emergency
Health

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

June 5, 2026 Evan Vega

The WHO has not declared a global health emergency over the drug-resistant tuberculosis strain linked to U.S. travelers as of mid-2025.

Insulin cost cap expansion
Health

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

June 4, 2026 Evan Vega
FDA Approves Gene-Editing Therapy
Health

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

June 3, 2026 Evan Vega
Hybrid closed-loop benefits diabetes
Health

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

June 2, 2026 Evan Vega
FDA approves RebiQuent treatment
Health

FDA approves first oral small‑molecule treatment RebiQuent for moderate to severe atopic dermatitis in adults

June 2, 2026 Evan Vega
Global Drug-Resistant Tuberculosis Emergency
Health

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

June 5, 2026 Evan Vega

The WHO has not declared a global health emergency over the drug-resistant tuberculosis strain linked to U.S. travelers as of mid-2025.

Insulin cost cap expansion
Health

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

June 4, 2026 Evan Vega
FDA Approves Gene-Editing Therapy
Health

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

June 3, 2026 Evan Vega
Hybrid closed-loop benefits diabetes
Health

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

June 2, 2026 Evan Vega
Global Drug-Resistant Tuberculosis Emergency
Health

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

June 5, 2026 Evan Vega

The WHO has not declared a global health emergency over the drug-resistant tuberculosis strain linked to U.S. travelers as of mid-2025.

Insulin cost cap expansion
Health

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

June 4, 2026 Evan Vega
FDA Approves Gene-Editing Therapy
Health

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

June 3, 2026 Evan Vega
Hybrid closed-loop benefits diabetes
Health

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

June 2, 2026 Evan Vega
FDA approves RebiQuent treatment
Health

FDA approves first oral small‑molecule treatment RebiQuent for moderate to severe atopic dermatitis in adults

June 2, 2026 Evan Vega
Global Drug-Resistant Tuberculosis Emergency
Health

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

June 5, 2026 Evan Vega

The WHO has not declared a global health emergency over the drug-resistant tuberculosis strain linked to U.S. travelers as of mid-2025.

Insulin cost cap expansion
Health

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

June 4, 2026 Evan Vega
FDA Approves Gene-Editing Therapy
Health

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

June 3, 2026 Evan Vega
Hybrid closed-loop benefits diabetes
Health

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

June 2, 2026 Evan Vega
Global Drug-Resistant Tuberculosis Emergency
Health

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

June 5, 2026 Evan Vega

The WHO has not declared a global health emergency over the drug-resistant tuberculosis strain linked to U.S. travelers as of mid-2025.

Insulin cost cap expansion
Health

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

June 4, 2026 Evan Vega
FDA Approves Gene-Editing Therapy
Health

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

June 3, 2026 Evan Vega
Hybrid closed-loop benefits diabetes
Health

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

June 2, 2026 Evan Vega
FDA approves RebiQuent treatment
Health

FDA approves first oral small‑molecule treatment RebiQuent for moderate to severe atopic dermatitis in adults

June 2, 2026 Evan Vega
Public Health
February 15, 2024 Evan Vega

Watch: The Feds May Reexamine Covid Protocols. Here’s Why You Should Care.

Céline Gounder, KFF Health News’ editor-at-large for public health, appeared Feb. 14 on “CBS Mornings” to discuss why the Centers

Read More
Public Health
February 15, 2024 Evan Vega

Early Detection May Help Kentucky Tamp Down Its Lung Cancer Crisis

Charlotte Huff Anthony Stumbo’s heart sank after the doctor shared his mother’s chest X-ray. “I remember that drive home, bringing

Read More
Public Health
February 15, 2024 Evan Vega

New Eligibility Rules Are a Financial Salve for Nearly 2 Million on Medi-Cal

Bernard J. Wolfson Millions of Medi-Cal beneficiaries can now save for a rainy day, keep an inheritance, or hold on

Read More
Asthma prevalance based on cannabis use in the past 30 days included 23.62% with no use, 28.72% with three to nine times and 31.38% with 40 or more times.
Infectious Disease
February 15, 2024 Evan Vega

Asthma prevalence increases with cannabis use among adolescents

February 14, 2024 4 min read Add topic to email alerts Receive an email when new articles are posted on

Read More
FTC, HHS examining cause of generic drug shortages
Public Health
February 15, 2024 Evan Vega

FTC, HHS examining cause of generic drug shortages

A variety of generic pills and capsules.  Nenov | Moment | Getty Images The Federal Trade Commission on Wednesday said

Read More
IDN0224VectorBorne_Graphic_01_WEB
Infectious Disease
February 14, 2024 Evan Vega

HHS launches largest US effort ever to reduce vector-borne diseases

February 14, 2024 2 min read Add topic to email alerts Receive an email when new articles are posted on

Read More
Public Health
February 14, 2024 Evan Vega

The No Surprises Act Comes With Some Surprises

The No Surprises Act, the landmark law intended to protect patients from surprise out-of-network medical bills, has come with, well,

Read More
Public Health
February 14, 2024 Evan Vega

For the Love of Health Care and Health Policy

Nothing melts our hearts like a health policy valentine. Readers made us swoon this season, writing poetic lines about prescription

Read More
Public Health
February 14, 2024 Evan Vega

California Prison Drug Overdoses Surge Again After Early Treatment Success

Don Thompson SACRAMENTO, Calif. — Drug overdose deaths in California state prisons rebounded to near record levels last year even

Read More
Biogen (BIIB) earnings Q4 2023
Public Health
February 14, 2024 Evan Vega

Biogen (BIIB) earnings Q4 2023

A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen on Tuesday reported fourth-quarter revenue and profit that shrank

Read More
  • ← Previous
  • Next →
Copyright © 2026 DAILYZ HEALTH NEWS. Powered by ColorMag and WordPress.